The biggest mistake made in currency cycles is to confuse revenue gain with pure earnings gain. A company may report stronger rupee revenue...

Founded in 2022 by Keshav Biyani and Prabhu Karthikeyan, Mumbai-based The Good Bug develops probiotic and gut-focused health products targe...

Botanic Healthcare, a nutraceutical maker based in Hyderabad, has successfully raised Rs. 250 crores in its latest equity funding round led...

Controversy arises as government considers shifting nutraceuticals to drug regulatory authority from FSSAI oversight. Industry experts expr...

The company recorded a revenue of Rs 220 crore, of which Rs 170 crore came in from products/medicines and the rest from services in FY22. T...

Donkey’s milk is similar to a human mother’s milk, and rich in vitamins and essential fatty acids.

Co-founded by former Goldman Sachs bankers in 2006, Everstone Capital is now the largest India-focused private equity investment firm.

OmniActive is a supplier of naturally sourced ingredients for eye health, weight management and heart health to global nutraceutical compan...

The group has set aside $25 million over a five-year period to fund the research and will even send the group's employees to the universiti...

Muhammed Majeed is eyeing cultivation of the monk fruit in India, a zero-calorie, natural sugar substitute that might be the answer to our ...

Among the 10 products that have been mentioned in the proposal are Sun Pharma's multi-vitamin capsule 'Revital', Pfizer's 'Ferradol' and Al...

The root cause of type 2 diabetes is systemic inflammation, which impacts insulin secretion and function.

Products of group's cosmetics arm, Johara, will be sold through Sami Direct, its direct-selling arm.

India Agri Business Fund is Asia's first private equity fund focused on the food and agribusiness sector in the country.

The increase in stake in US Nutraceuticals was at a discount compared to the Rs 48 crore it paid for the initial 51% stake.

After Future Group tied up with NIF, Britannia Industries has expressed interest in NIF’s patented herbal food products.

Fidelity Investments is in advanced talks to buy 12-14% stake in the Bangalore-based biotech firm Avesthagen for $10-12 million.